Xiao Juan Li
Director/Board Member bei CHINA NATIONAL MEDICINES CORPORATION LTD.
Profil
Xiao Juan Li is currently a Director at China National Medicines Co., Ltd.
Prior to this, she worked as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and as a Manager-Investment Planning & Audit Division at China National Pharmaceutical Industry Corp.
Ltd.
Aktive Positionen von Xiao Juan Li
Unternehmen | Position | Beginn |
---|---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 07.04.2022 |
Ehemalige bekannte Positionen von Xiao Juan Li
Unternehmen | Position | Ende |
---|---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Corporate Officer/Principal | - |
JIANGSU HENGRUI MEDICINE CO., LTD. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Health Technology |